These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 21436355

  • 1. ADRB2 Gly16Arg polymorphism, asthma control and lung function decline.
    Rebordosa C, Kogevinas M, Guerra S, Castro-Giner F, Jarvis D, Cazzoletti L, Pin I, Siroux V, Wjst M, Antò JM, de Marco R, Estivill X, Corsico AG, Nielsen R, Janson C.
    Eur Respir J; 2011 Nov; 38(5):1029-35. PubMed ID: 21436355
    [Abstract] [Full Text] [Related]

  • 2. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM.
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [Abstract] [Full Text] [Related]

  • 3. Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort.
    Zuurhout MJ, Vijverberg SJ, Raaijmakers JA, Koenderman L, Postma DS, Koppelman GH, Maitland-van der Zee AH.
    Pharmacogenomics; 2013 Dec; 14(16):1965-71. PubMed ID: 24279851
    [Abstract] [Full Text] [Related]

  • 4. Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.
    Giubergia V, Gravina L, Castaños C, Chertkoff L.
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):156-60. PubMed ID: 23548523
    [Abstract] [Full Text] [Related]

  • 5. The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma.
    Konno S, Hizawa N, Makita H, Shimizu K, Sakamoto T, Kokubu F, Saito T, Endo T, Ninomiya H, Iijima H, Kaneko N, Ito YM, Nishimura M, J-Blossom Study Group.
    Pharmacogenet Genomics; 2014 May; 24(5):246-55. PubMed ID: 24681963
    [Abstract] [Full Text] [Related]

  • 6. Is Gly16Arg β2 Receptor Polymorphism Related to Impulse Oscillometry in a Real-Life Asthma Clinic Setting?
    Jabbal S, Manoharan A, Lipworth J, Anderson W, Short P, Lipworth B.
    Lung; 2016 Apr; 194(2):267-71. PubMed ID: 26880163
    [Abstract] [Full Text] [Related]

  • 7. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma.
    Slankard M, Michelis MA, Mansukhani M, McGoey B, Paige A, Andrews H, Lederer D, Canfield S, DiMango E.
    J Asthma; 2016 Oct; 53(8):783-9. PubMed ID: 27050801
    [Abstract] [Full Text] [Related]

  • 8. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
    Niu LM, Liang Y, Xu M, Zhang YY, Zhang Y, He B.
    Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
    [Abstract] [Full Text] [Related]

  • 9. The emerging role of tiotropium for patients with asthma.
    Bollmeier SG, Lee SY.
    Ann Pharmacother; 2013 May; 47(5):704-13. PubMed ID: 23613100
    [Abstract] [Full Text] [Related]

  • 10. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
    Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, Anderson WH, Emmett AH, Ortega HG.
    Am J Respir Crit Care Med; 2010 Apr 01; 181(7):676-87. PubMed ID: 19910613
    [Abstract] [Full Text] [Related]

  • 11. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM.
    J Allergy Clin Immunol; 2011 Aug 01; 128(2):315-22. PubMed ID: 21807250
    [Abstract] [Full Text] [Related]

  • 12. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep 01; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

  • 13. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May 01; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 14. Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.
    Kim SH, Ye YM, Hur GY, Lee HY, Jee YK, Lee SH, Holloway JW, Park HS.
    Yonsei Med J; 2009 Apr 30; 50(2):182-8. PubMed ID: 19430548
    [Abstract] [Full Text] [Related]

  • 15. Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol.
    Basu K, Palmer CN, Tavendale R, Lipworth BJ, Mukhopadhyay S.
    J Allergy Clin Immunol; 2009 Dec 30; 124(6):1188-94.e3. PubMed ID: 19800676
    [Abstract] [Full Text] [Related]

  • 16. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
    Isaza C, Sepúlveda-Arias JC, Agudelo BI, Arciniegas W, Henao J, Porras GL, Beltrán L.
    Pediatr Pulmonol; 2012 Sep 30; 47(9):848-55. PubMed ID: 22328447
    [Abstract] [Full Text] [Related]

  • 17. Influence of β(2)-adrenergic receptor polymorphism on methacholine hyperresponsiveness in asthmatic patients.
    Manoharan A, Anderson WJ, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2013 Mar 30; 110(3):161-4. PubMed ID: 23548524
    [Abstract] [Full Text] [Related]

  • 18. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
    Clin Ther; 2009 Nov 30; 31(11):2574-83. PubMed ID: 20110003
    [Abstract] [Full Text] [Related]

  • 19. Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.
    Turner S, Francis B, Vijverberg S, Pino-Yanes M, Maitland-van der Zee AH, Basu K, Bignell L, Mukhopadhyay S, Tavendale R, Palmer C, Hawcutt D, Pirmohamed M, Burchard EG, Lipworth B, Pharmacogenomics in Childhood Asthma Consortium.
    J Allergy Clin Immunol; 2016 Jul 30; 138(1):107-113.e5. PubMed ID: 26774659
    [Abstract] [Full Text] [Related]

  • 20. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
    Metzger NL, Kockler DR, Gravatt LA.
    Ann Pharmacother; 2008 Jun 30; 42(6):874-81. PubMed ID: 18430791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.